Skip to main content

Table 3 Comparison of SF-12 scores in the control group and silver needle group (mean ± SD)

From: Efficacy of silver needle therapy for the treatment of chronic nonspecific low back pain: a prospective, single-center, randomized, parallel-controlled clinical trial

 

Control group

Silver needle group

P value

Baseline

19.7 ± 3.0

19.0 ± 3.3

0.251

1 month

38.7 ± 18.6

55.7 ± 5.2

< 0.001

2 months

63.0 ± 13.9

71.8 ± 4.5

< 0.001

3 months

68.1 ± 2.4

71.7 ± 2.7

< 0.001

6 months

68.7 ± 3.0

72.4 ± 3.2

< 0.001

  1. SF-12 Short-Form 12 of quality of life
Back to article page

Trials

ISSN: 1745-6215